Lumichrome

Identification

Generic Name
Lumichrome
DrugBank Accession Number
DB04345
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 242.2334
Monoisotopic: 242.080375584
Chemical Formula
C12H10N4O2
Synonyms
  • 7,8-dimethylalloxazine
  • 7,8-dimethylbenzo[g]pteridine-2,4(1H,3H)-dione
  • Lumichrome
  • Riboflavin lumichrome
External IDs
  • NSC-96911

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UFlavin reductase (NADPH)Not AvailableHumans
URiboflavin biosynthesis protein RibFNot AvailableThermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as flavins. These are compounds containing a flavin (7,8-dimethyl-benzo[g]pteridine-2,4-dione) moiety, with a structure characterized by an isoalloaxzine tricyclic ring.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Pteridines and derivatives
Sub Class
Alloxazines and isoalloxazines
Direct Parent
Flavins
Alternative Parents
Quinoxalines / Pyrimidones / Pyrazines / Benzenoids / Vinylogous amides / Heteroaromatic compounds / Ureas / Lactams / Azacyclic compounds / Organopnictogen compounds
show 4 more
Substituents
Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Diazanaphthalene / Flavin / Heteroaromatic compound / Hydrocarbon derivative / Lactam / Organic nitrogen compound / Organic oxide
show 10 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
7,8-dimethylbenzo[g]pteridine-2,4-dione (CHEBI:37323) / a small molecule (CPD-605)
Affected organisms
Not Available

Chemical Identifiers

UNII
99U1UDJ2HM
CAS number
1086-80-2
InChI Key
ZJTJUVIJVLLGSP-UHFFFAOYSA-N
InChI
InChI=1S/C12H10N4O2/c1-5-3-7-8(4-6(5)2)14-10-9(13-7)11(17)16-12(18)15-10/h3-4H,1-2H3,(H2,14,15,16,17,18)
IUPAC Name
7,8-dimethyl-1H,2H,3H,4H-benzo[g]pteridine-2,4-dione
SMILES
CC1=CC2=NC3=C(N=C2C=C1C)C(=O)NC(=O)N3

References

General References
Not Available
KEGG Compound
C01727
PubChem Compound
5326566
PubChem Substance
46505545
ChemSpider
4483963
ChEBI
37323
ZINC
ZINC000012446789
PDBe Ligand
LUM
PDB Entries
1he5 / 1s4m / 2cc6 / 2cc7 / 6gpv

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)>300 °CPhysProp
Predicted Properties
PropertyValueSource
Water Solubility0.0511 mg/mLALOGPS
logP1.18ALOGPS
logP2.73Chemaxon
logS-3.7ALOGPS
pKa (Strongest Acidic)8.85Chemaxon
pKa (Strongest Basic)-0.14Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area83.98 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity65.19 m3·mol-1Chemaxon
Polarizability24.37 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9952
Blood Brain Barrier+0.9385
Caco-2 permeable-0.6664
P-glycoprotein substrateSubstrate0.5174
P-glycoprotein inhibitor INon-inhibitor0.8416
P-glycoprotein inhibitor IINon-inhibitor0.9893
Renal organic cation transporterNon-inhibitor0.9219
CYP450 2C9 substrateNon-substrate0.6912
CYP450 2D6 substrateNon-substrate0.839
CYP450 3A4 substrateNon-substrate0.6577
CYP450 1A2 substrateInhibitor0.9136
CYP450 2C9 inhibitorNon-inhibitor0.9606
CYP450 2D6 inhibitorNon-inhibitor0.9716
CYP450 2C19 inhibitorNon-inhibitor0.943
CYP450 3A4 inhibitorNon-inhibitor0.956
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.975
Ames testNon AMES toxic0.6527
CarcinogenicityNon-carcinogens0.9393
BiodegradationNot ready biodegradable0.9001
Rat acute toxicity2.4426 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9596
hERG inhibition (predictor II)Non-inhibitor0.8262
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-MSGC-MSsplash10-001r-5900000000-1e37baccc742ae47cb80
GC-MS Spectrum - GC-MS (2 TMS)GC-MSsplash10-0fe0-4927000000-0ea568b1e8aa60791c9e
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-00r2-0950000000-e5b9e134a75f4dca4bf0
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0f72-1914000000-c5b81d41885f62e10888
MS/MS Spectrum - Linear Ion Trap , negativeLC-MS/MSsplash10-0002-0900000000-6d4a787c35bdc162a108
MS/MS Spectrum - Linear Ion Trap , negativeLC-MS/MSsplash10-0002-0900000000-49685e019b9afa0131a8
LC-MS/MS Spectrum - LC-ESI-IT , positiveLC-MS/MSsplash10-00xr-1960000000-52c2b7935c2b9969b017
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-006t-0910000000-4c7ccdec411ac9f28eb8
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-006t-0910000000-3a15eb2aac260d80437c
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0006-0090000000-26a2de0527004c85c908
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-0090000000-12513d0a41b786227db7
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0006-0090000000-b022a4c205e8914c0bd3
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-0390000000-41fb06a782bce427b6fd
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0kmi-0920000000-46abaf0e9e74771f15c4
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-006x-5920000000-e1cc781aca3ba66d85de
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-164.613026
predicted
DarkChem Lite v0.1.0
[M-H]-164.617826
predicted
DarkChem Lite v0.1.0
[M-H]-156.08116
predicted
DeepCCS 1.0 (2019)
[M+H]+165.341026
predicted
DarkChem Lite v0.1.0
[M+H]+165.681926
predicted
DarkChem Lite v0.1.0
[M+H]+158.43916
predicted
DeepCCS 1.0 (2019)
[M+Na]+165.592026
predicted
DarkChem Lite v0.1.0
[M+Na]+164.5323
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Riboflavin reductase (nadph) activity
Specific Function
Broad specificity oxidoreductase that catalyzes the NADPH-dependent reduction of a variety of flavins, such as riboflavin, FAD or FMN, biliverdins, methemoglobin and PQQ (pyrroloquinoline quinone)....
Gene Name
BLVRB
Uniprot ID
P30043
Uniprot Name
Flavin reductase (NADPH)
Molecular Weight
22119.215 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Kind
Protein
Organism
Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)
Pharmacological action
Unknown
General Function
Riboflavin kinase activity
Specific Function
Not Available
Gene Name
Not Available
Uniprot ID
Q9WZW1
Uniprot Name
Riboflavin biosynthesis protein
Molecular Weight
33613.56 Da
References
  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52